(TSM) Taiwan Semiconductor - Ratings and Ratios
Wafers, Chips, Packaging, Testing, Masks
Dividends
| Dividend Yield | 1.61% |
| Yield on Cost 5y | 4.82% |
| Yield CAGR 5y | 7.97% |
| Payout Consistency | 96.4% |
| Payout Ratio | 32.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 34.8% |
| Value at Risk 5%th | 53.1% |
| Relative Tail Risk | -7.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.08 |
| Alpha | 33.20 |
| CAGR/Max DD | 1.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.460 |
| Beta | 1.457 |
| Beta Downside | 1.520 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.82% |
| Mean DD | 7.72% |
| Median DD | 5.92% |
Description: TSM Taiwan Semiconductor December 02, 2025
Taiwan Semiconductor Manufacturing Company Limited (TSMC) is the world’s largest dedicated semiconductor foundry, offering end-to-end services-from wafer fabrication and mask production to packaging, testing, and engineering support-across a broad portfolio that includes CMOS logic, mixed-signal, RF, embedded memory, and bipolar CMOS technologies.
Its chips power high-performance computing, smartphones, IoT devices, automotive electronics, and consumer digital products, making TSMC a critical supplier for the global technology ecosystem.
Key recent metrics: FY 2023 revenue reached ≈ US $79.5 billion with a 95 % capacity utilization rate; the firm invested roughly US $30 billion in 2023-2024 capital expenditures to expand 5 nm and 3 nm production capacity, positioning itself ahead of the industry’s node transition curve.
Primary economic drivers include sustained demand for AI-accelerated workloads, the U.S. CHIPS and Science Act incentives that encourage on-shore fab investment, and macro-level supply-chain tightening that favors TSMC’s scale and advanced-process lead.
For a deeper quantitative view of TSM’s valuation metrics, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (1586.82b TTM) > 0 and > 6% of Revenue (6% = 217.89b TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -2.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 59.48% (prev 61.48%; Δ -2.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.30 (>3.0%) and CFO 2169.67b > Net Income 1586.82b (YES >=105%, WARN >=100%) |
| Net Debt (-1514.10b) to EBITDA (2732.11b) ratio: -0.55 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.69 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (5.19b) change vs 12m ago -0.00% (target <= -2.0% for YES) |
| Gross Margin 58.98% (prev 54.45%; Δ 4.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 53.72% (prev 43.00%; Δ 10.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 158.0 (EBITDA TTM 2732.11b / Interest Expense TTM 11.85b) >= 6 (WARN >= 3) |
Altman Z'' 8.13
| (A) 0.29 = (Total Current Assets 3436.01b - Total Current Liabilities 1275.91b) / Total Assets 7354.11b |
| (B) 0.65 = Retained Earnings (Balance) 4753.53b / Total Assets 7354.11b |
| (C) 0.28 = EBIT TTM 1872.34b / Avg Total Assets 6759.88b |
| (D) 2.12 = Book Value of Equity 4924.95b / Total Liabilities 2318.53b |
| Total Rating: 8.13 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 89.54
| 1. Piotroski 7.50pt |
| 2. FCF Yield 1.96% |
| 3. FCF Margin 24.50% |
| 4. Debt/Equity 0.19 |
| 5. Debt/Ebitda -0.55 |
| 6. ROIC - WACC (= 20.45)% |
| 7. RoE 34.44% |
| 8. Rev. Trend 89.79% |
| 9. EPS Trend 64.42% |
What is the price of TSM shares?
Over the past week, the price has changed by +0.49%, over one month by -0.38%, over three months by +24.93% and over the past year by +48.00%.
Is TSM a buy, sell or hold?
- Strong Buy: 11
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the TSM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 341.9 | 16.7% |
| Analysts Target Price | 341.9 | 16.7% |
| ValueRay Target Price | 399.7 | 36.4% |
TSM Fundamental Data Overview November 29, 2025
P/E Trailing = 30.0166
P/E Forward = 24.2131
P/S = 0.4141
P/B = 9.4644
P/EG = 1.4227
Beta = 1.26
Revenue TTM = 3631.43b TWD
EBIT TTM = 1872.34b TWD
EBITDA TTM = 2732.11b TWD
Long Term Debt = 918.23b TWD (from longTermDebt, last quarter)
Short Term Debt = 76.23b TWD (from shortTermDebt, last quarter)
Debt = 956.66b TWD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1514.10b TWD (from netDebt column, last quarter)
Enterprise Value = 45454.47b TWD (47248.87b + Debt 956.66b - CCE 2751.06b)
Interest Coverage Ratio = 158.0 (Ebit TTM 1872.34b / Interest Expense TTM 11.85b)
FCF Yield = 1.96% (FCF TTM 889.87b / Enterprise Value 45454.47b)
FCF Margin = 24.50% (FCF TTM 889.87b / Revenue TTM 3631.43b)
Net Margin = 43.70% (Net Income TTM 1586.82b / Revenue TTM 3631.43b)
Gross Margin = 58.98% ((Revenue TTM 3631.43b - Cost of Revenue TTM 1489.74b) / Revenue TTM)
Gross Margin QoQ = 59.45% (prev 58.62%)
Tobins Q-Ratio = 6.18 (Enterprise Value 45454.47b / Total Assets 7354.11b)
Interest Expense / Debt = 0.31% (Interest Expense 2.96b / Debt 956.66b)
Taxrate = 14.01% (73.61b / 525.37b)
NOPAT = 1609.99b (EBIT 1872.34b * (1 - 14.01%))
Current Ratio = 2.69 (Total Current Assets 3436.01b / Total Current Liabilities 1275.91b)
Debt / Equity = 0.19 (Debt 956.66b / totalStockholderEquity, last quarter 4998.31b)
Debt / EBITDA = -0.55 (Net Debt -1514.10b / EBITDA 2732.11b)
Debt / FCF = -1.70 (Net Debt -1514.10b / FCF TTM 889.87b)
Total Stockholder Equity = 4608.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.58% (Net Income 1586.82b / Total Assets 7354.11b)
RoE = 34.44% (Net Income TTM 1586.82b / Total Stockholder Equity 4608.02b)
RoCE = 33.88% (EBIT 1872.34b / Capital Employed (Equity 4608.02b + L.T.Debt 918.23b))
RoIC = 31.61% (NOPAT 1609.99b / Invested Capital 5093.08b)
WACC = 11.16% (E(47248.87b)/V(48205.52b) * Re(11.38%) + D(956.66b)/V(48205.52b) * Rd(0.31%) * (1-Tc(0.14)))
Discount Rate = 11.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.00%
[DCF Debug] Terminal Value 71.36% ; FCFE base≈890.19b ; Y1≈1098.18b ; Y5≈1873.65b
Fair Price DCF = 3630 (DCF Value 18826.16b / Shares Outstanding 5.19b; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 64.42 | EPS CAGR: 28.21% | SUE: 4.0 | # QB: 3
Revenue Correlation: 89.79 | Revenue CAGR: 24.27% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.75 | Chg30d=+0.050 | Revisions Net=+3 | Analysts=7
EPS next Year (2026-12-31): EPS=12.49 | Chg30d=+0.043 | Revisions Net=+2 | Growth EPS=+20.8% | Growth Revenue=+20.5%
Additional Sources for TSM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle